Automated extraction of body composition metrics from abdominal CT or MR imaging: A scoping review.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 09 08 2024
revised: 13 09 2024
accepted: 25 09 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: aheadofprint

Résumé

To review methodological approaches for automated segmentation of subcutaneous adipose tissue, visceral adipose tissue, and skeletal muscle from abdominal cross-sectional imaging for body composition analysis. Four databases were searched for publications describing automated segmentation of subcutaneous adipose tissue, visceral adipose tissue, and/or skeletal muscle from abdominal CT or MR imaging between 2019 and 2023. Included reports were evaluated to assess how imaging modality, cohort size, vertebral level, model dimensionality, and use of a volume or single slice affected segmentation accuracy and/or clinical utility. Exclusion criteria included reports not in English language, manual or semi-automated segmentation methods, reports prior to 2019 or solely of paediatric patients, and those not describing the use of abdominal CT or MR. After exclusions, 172 reports were included in the review. CT imaging was utilised approximately four times as often as MRI, and segmentation accuracy did not significantly differ between the two modalities. Cohort size had no significant effect on segmentation accuracy. There was little evidence to refute the current practice of extracting body composition metrics from the third lumbar vertebral level. There was no clear benefit of using a 3D model to perform segmentation over a 2D approach. Automated segmentation of intra-abdominal soft tissues for body composition analysis is an intense area of research activity. Segmentation accuracy is not affected by cross-sectional imaging modality. Extracting metrics from a single slice at the third lumbar vertebral level is a common approach, however, extracting metrics from a volumetric slab surrounding this level may increase the resilience of the technique, which is important for clinical translation. A paucity of publicly available datasets led to most reports using different data sources, preventing direct comparison of segmentation techniques. Future efforts should prioritise creating a standardised dataset to facilitate benchmarking of different algorithms and subsequent clinical adoption.

Identifiants

pubmed: 39368243
pii: S0720-048X(24)00480-7
doi: 10.1016/j.ejrad.2024.111764
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111764

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christopher Winder (C)

UKRI CDT in AI for Medical Diagnosis and Care, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK; School of Computing, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK. Electronic address: scccw@leeds.ac.uk.

Matthew Clark (M)

Department of Radiology, St.James University Hospital, Beckett St, Harehills, LS9 7TF, Leeds, UK. Electronic address: matt.clark1@nhs.net.

Russell Frood (R)

Department of Radiology, St.James University Hospital, Beckett St, Harehills, LS9 7TF, Leeds, UK; CRUK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK. Electronic address: russellfrood@nhs.net.

Lesley Smith (L)

CRUK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK. Electronic address: L.F.Smith@leeds.ac.uk.

Andrew Bulpitt (A)

School of Computing, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK. Electronic address: A.J.Bulpitt@leeds.ac.uk.

Gordon Cook (G)

CRUK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK; Leeds Cancer Centre, St. James University Hospital, Beckett St, Harehills, LS9 7TF, Leeds, UK. Electronic address: g.cook@leeds.ac.uk.

Andrew Scarsbrook (A)

Department of Radiology, St.James University Hospital, Beckett St, Harehills, LS9 7TF, Leeds, UK; Leeds Cancer Centre, St. James University Hospital, Beckett St, Harehills, LS9 7TF, Leeds, UK; Leeds Institute of Medical Research, University of Leeds, Woodhouse, LS2 9JT, Leeds, UK. Electronic address: a.f.scarsbrook@leeds.ac.uk.

Classifications MeSH